Back to top
more

Avanos Medical (AVNS)

(Delayed Data from NYSE)

$17.85 USD

17.85
230,915

-0.86 (-4.60%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $17.83 -0.02 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for AVNS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for AVANOS MEDICAL, INC falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 88 128 119 112 205
Receivables 143 168 131 168 164
Notes Receivable 0 0 0 0 0
Inventories 163 190 150 169 146
Other Current Assets 93 14 19 19 24
Total Current Assets 487 500 419 467 539
Net Property & Equipment 117 164 168 175 185
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 7 5 10 10 16
Intangibles 1,036 1,070 943 960 985
Deposits & Other Assets 19 18 17 12 11
Total Assets 1,692 1,787 1,595 1,673 1,800
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 56 68 56 68 83
Current Portion Long-Term Debt 9 6 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 93 99 68 83 115
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 64 0 0 0 0
Total Current Liabilities 235 186 139 166 213
Mortgages 0 0 0 0 0
Deferred Taxes/Income 24 25 10 6 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 159 226 130 180 248
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 10 24 9 11 11
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 456 496 331 416 534
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,664 1,646 1,629 1,609 1,594
Retained Earnings -315 -253 -310 -316 -288
Other Equity -27 -36 -34 -28 -32
Treasury Stock 86 67 21 10 9
Total Shareholder's Equity 1,236 1,291 1,264 1,257 1,265
Total Liabilities & Shareholder's Equity 1,692 1,787 1,595 1,673 1,800
Total Common Equity 1,236 1,291 1,264 1,257 1,265
Shares Outstanding 46.40 46.50 48.10 47.80 47.90
Book Value Per Share 26.64 27.77 26.28 26.29 26.41

Fiscal Year End for AVANOS MEDICAL, INC falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 88 107 82 96
Receivables NA 143 145 152 143
Notes Receivable NA 0 0 0 0
Inventories NA 163 157 148 200
Other Current Assets NA 93 116 125 15
Total Current Assets NA 487 525 507 454
Net Property & Equipment NA 117 117 123 164
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 7 4 4 5
Intangibles NA 1,036 1,034 985 1,066
Deposits & Other Assets NA 19 18 19 19
Total Assets NA 1,692 1,725 1,667 1,735
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 56 52 65 60
Current Portion Long-Term Debt NA 9 6 6 6
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 93 97 73 81
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 64 3 3 0
Total Current Liabilities NA 235 171 161 159
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 24 29 22 25
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 159 258 203 205
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 16 15 16
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 456 503 432 436
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,664 1,660 1,655 1,651
Retained Earnings NA -315 -325 -322 -254
Other Equity NA -27 -33 -28 -31
Treasury Stock NA 86 80 71 68
Total Shareholder's Equity NA 1,236 1,222 1,235 1,299
Total Liabilities & Shareholder's Equity NA 1,692 1,725 1,667 1,735
Total Common Equity 0 1,236 1,222 1,235 1,299
Shares Outstanding 46.20 46.40 46.40 46.60 46.60
Book Value Per Share 0.00 26.64 26.34 26.50 27.87